Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Positive Prognosis For Biotech ETFsTom Lydon • Mon, May 13
-
Biotech ETFs Are Outperforming The S&P 500David Zanoni • Fri, Sep 21, 2012
-
Election Could Make Or Break Health Care ETFsTom Lydon • Tue, Sep 18, 2012
-
Biotech ETFs Cool After Strong RunTom Lydon • Tue, Aug 14, 2012
-
Follow The Next Breakthrough Drug Makers With Biotechnology ETFsTom Lydon • Fri, Aug 3, 2012
To learn more about Seeking Alpha Pro, click here.
-
Re-Evaluating Your Healthcare Exposure: A Sector ETF OverviewMorningstar • Thu, Mar 4, 2010
-
Block Traders’ XBI Forecast: A SequelPeter F. Way • Wed, Nov 18, 2009
-
Positive Prognosis For Biotech ETFsTom Lydon • Mon, May 13
-
Biotech ETFs Are Outperforming The S&P 500David Zanoni • Fri, Sep 21, 2012
-
Election Could Make Or Break Health Care ETFsTom Lydon • Tue, Sep 18, 2012
-
Biotech ETFs Cool After Strong RunTom Lydon • Tue, Aug 14, 2012
-
Follow The Next Breakthrough Drug Makers With Biotechnology ETFsTom Lydon • Fri, Aug 3, 2012
There are no Transcripts on XBI.
-
at CNBC.com (Apr 16, 2013)
-
at CNBC.com (Jun 28, 2012)
-
at CNBC.com (May 7, 2012)
-
at CNBC.com (Apr 30, 2012)
-
at MarketWatch.com (Jun 20, 2011)
-
at CNBC.com (Feb 10, 2011)
-
at CNBC.com (Dec 6, 2010)
-
at CNBC.com (Dec 2, 2010)
-
at CNBC.com (Oct 25, 2010)
-
at CNBC.com (Sep 23, 2010)
-
at CNBC.com (Aug 12, 2010)
-
at CNBC.com (Jul 29, 2010)
-
at CNBC.com (Jul 28, 2010)
XBI vs. ETF Alternatives
XBI Description
The SPDR® S&P® Biotech ETF, before expenses, seeks to closely match the returns and characteristics of the S&P Biotechnology Select IndustryTM Index. Our approach is designed to provide portfolios with low portfolio turnover, accurate tracking, and lower costs.
See more details on sponsor's website
See more details on sponsor's website
Sector: Healthcare
Country: United States
Key Info
- In Your Portfolio: A Guide to Sector ETFs, A Guide to Healthcare, Pharma and Biotech ETFs
- Asset Class Performance: Sectors




